The Research of French PaRole OncO : A Peer Supported Program for Cancer Patients
NCT ID: NCT06817655
Last Updated: 2025-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
720 participants
INTERVENTIONAL
2025-03-15
2027-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:
1. Evaluating clinical and psychosocial parameters
2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Which Health-care Professional(s) to Talk About Advance Care Planning ?
NCT06376799
Integrated Care Pathway in Oncology (PASSION)
NCT04235556
Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology
NCT07256444
Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' With Cancer
NCT03659123
Efficacy Study on Quality of Life Criteria of a Digital Application on Any Cellphone (OnKO-Tips&Tricks) for Adolescents and Young Adults Diagnosed With Cancer
NCT05350631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:
1. Evaluating clinical and psychosocial parameters
2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supportive care (PaRole OncO France program)
Patients participate in the PaRole OncO France program for which they are matched with a patient advisor and followed throughout treatment in person and/or phone.
PaRole OncO France : Individual peer support
Following the development of the peer support program "PaRole OncO France", we are now proceeding with its implementation and evaluation through a pilot study. This study aims to derive both implementation-related and clinically relevant results.
Prior to their assignment, all peer helpers undergo a comprehensive training course to ensure they are well-equipped for their role.
Patients receive individual peer support during their treatment visits, providing real-time assistance and support within the clinical setting.
The study incorporates three key measurement time points:
1. Baseline measurement (before the intervention)
2. After the intervention
3. Follow-up measurement (1months after the first intervention)
4. Follow-up measurement (6 months after the first intervention)
At each time points, participants will complete a set of standardized questionnaires. These instruments are designed to capture relevant outcomes and experiences related to the peer support intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PaRole OncO France : Individual peer support
Following the development of the peer support program "PaRole OncO France", we are now proceeding with its implementation and evaluation through a pilot study. This study aims to derive both implementation-related and clinically relevant results.
Prior to their assignment, all peer helpers undergo a comprehensive training course to ensure they are well-equipped for their role.
Patients receive individual peer support during their treatment visits, providing real-time assistance and support within the clinical setting.
The study incorporates three key measurement time points:
1. Baseline measurement (before the intervention)
2. After the intervention
3. Follow-up measurement (1months after the first intervention)
4. Follow-up measurement (6 months after the first intervention)
At each time points, participants will complete a set of standardized questionnaires. These instruments are designed to capture relevant outcomes and experiences related to the peer support intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with newly diagnosed or recurrent cancer (urological, digestive, mammary, pulmonary, ORL, peritoneal carcinosis, melanoma, oncohaematology)
* French-speaking patients
* Patients adivsors :
* Patient advisors will be past cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
* French-speaking patients
Exclusion Criteria
* Not followed in one of the participating units
* Persons deprived of their liberty by judicial or administrative decision
* Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
* Patient advisors :
* Recurrence of the disease
* Currently undergoing treatment for active cancer
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Lyon, , France
Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL23_1301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.